Search research articles
Contact Us
Filters
Showing results (121-130 of 209) with videos related to
Page
of 21
Sort By:
Dermatology and Therapy
|
November 24, 2021
Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management
Amy C M Musiek, Kerri E Rieger, Martine Bagot, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 1, 2021
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience
N Nora Bennani, Aung M Tun, Kenneth R Carson, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 19, 2021
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience
N Nora Bennani, Aung M Tun, Kenneth R Carson, et al.
Blood Advances
|
February 9, 2021
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project
Andrei Shustov, Maria Elena Cabrera, Monica Civallero, et al.
Blood Advances
|
January 25, 2024
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
Kurt S Bantilan, Alexandra N Smith, Matthew J Maurer, et al.
Haematologica
|
September 5, 2024
Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience
Giulio Cassanello, Esther Drill, Alfredo Rivas-Delgado, et al.
Aesthetic Surgery Journal
|
November 24, 2022
Response to: What Is Missing From the 2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL?
Fabio Santanelli di Pompeo, Mark W Clemens, Michael Atlan, et al.
Blood
|
February 17, 2019
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
Sven Borchmann, Erel Joffe, Craig H Moskowitz, et al.
Hematological Oncology
|
September 9, 2022
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project
Carlos Chiattone, Monica Civallero, Thais Fischer, et al.
Blood Advances
|
April 26, 2022
Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2
Kerry J Savage, Steven M Horwitz, Ranjana Advani, et al.
Page
of 21
Search research articles
Search
Showing results (121-130 of 209) with videos related to
Sort By:
Page
of 21
Dermatology and Therapy
|
November 24, 2021
Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management
Amy C M Musiek, Kerri E Rieger, Martine Bagot, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 1, 2021
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience
N Nora Bennani, Aung M Tun, Kenneth R Carson, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 19, 2021
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience
N Nora Bennani, Aung M Tun, Kenneth R Carson, et al.
Blood Advances
|
February 9, 2021
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project
Andrei Shustov, Maria Elena Cabrera, Monica Civallero, et al.
Blood Advances
|
January 25, 2024
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
Kurt S Bantilan, Alexandra N Smith, Matthew J Maurer, et al.
Haematologica
|
September 5, 2024
Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience
Giulio Cassanello, Esther Drill, Alfredo Rivas-Delgado, et al.
Aesthetic Surgery Journal
|
November 24, 2022
Response to: What Is Missing From the 2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL?
Fabio Santanelli di Pompeo, Mark W Clemens, Michael Atlan, et al.
Blood
|
February 17, 2019
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
Sven Borchmann, Erel Joffe, Craig H Moskowitz, et al.
Hematological Oncology
|
September 9, 2022
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project
Carlos Chiattone, Monica Civallero, Thais Fischer, et al.
Blood Advances
|
April 26, 2022
Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2
Kerry J Savage, Steven M Horwitz, Ranjana Advani, et al.
Page
of 21